Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Hematology. American Society of Hematology. Education Program|November 21, 2007
Are there circumstances in which phase 2 study results should be practice-changing?Marcie R Tomblyn, J Douglas RizzoSeminars in Oncology|August 27, 2003
New developments in antibody therapy for acute myeloid leukemiaMarcie R Tomblyn, Martin S TallmanSeminars in Hematology|January 7, 2012
Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantationGerard Socié, J Douglas RizzoBone Marrow Transplantation|January 8, 2013
Surviving the cure: long term followup of hematopoietic cell transplant recipientsN S Majhail, J Douglas RizzoBlood|October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantationChristopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantationJanelle B Perkins, Jongphil Kim, Claudio Anasetti, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 7, 2014
Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivorsKelly Kenzik, I-Chan Huang, J Douglas Rizzo, et al.American Journal of Hematology|April 1, 2003
Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplantMichael D Rosenblum, Christopher N Bredeson, Chung-Che Chang, et al.Journal of Oncology Practice|March 2, 2011
American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancerJ Douglas Rizzo, Melissa Brouwers, Patricia Hurley, et al.Pageof 14